Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianqi An

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|June 21, 2021
Conditional Cell Reprogramming in Modeling Digestive System DiseasesRuihua Zhao, Rui Li, Tianqi An, et al.
Biological Procedures Online|July 3, 2025
Mitigating Tumor Recurrence through Mitochondrial Metabolism Inhibition: A Novel NIR Laser-Induced Therapeutic StrategyYao Liu, Zujun Que, Tianqi An, et al.
Biological Procedures Online|November 11, 2025
Inhalable Herbal Nano-Liposomes Co-Delivering Astragaloside IV and Polyphyllin VII Reprogram Immunosuppressive Microenvironment To Overcome Anti-PD-1 Resistance in NSCLCYao Liu, Tianqi An, Zujun Que, et al.
European Journal of Medicinal Chemistry|May 24, 2021
Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoproteinXinguang Cao, Rui Li, Huihua Xiong, et al.
Frontiers in Oncology|October 30, 2023
Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory studyRuihua Zhao, Tianqi An, Min Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 26, 2024
Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancersTianqi An, Qiu Hui, Hong Zong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|June 21, 2021
Conditional Cell Reprogramming in Modeling Digestive System DiseasesRuihua Zhao, Rui Li, Tianqi An, et al.
Biological Procedures Online|July 3, 2025
Mitigating Tumor Recurrence through Mitochondrial Metabolism Inhibition: A Novel NIR Laser-Induced Therapeutic StrategyYao Liu, Zujun Que, Tianqi An, et al.
Biological Procedures Online|November 11, 2025
Inhalable Herbal Nano-Liposomes Co-Delivering Astragaloside IV and Polyphyllin VII Reprogram Immunosuppressive Microenvironment To Overcome Anti-PD-1 Resistance in NSCLCYao Liu, Tianqi An, Zujun Que, et al.
European Journal of Medicinal Chemistry|May 24, 2021
Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoproteinXinguang Cao, Rui Li, Huihua Xiong, et al.
Frontiers in Oncology|October 30, 2023
Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory studyRuihua Zhao, Tianqi An, Min Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 26, 2024
Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancersTianqi An, Qiu Hui, Hong Zong, et al.
Pageof 1